Drugs / Meningococcal Groups A, C, W and Y Conjugate Vaccine (MenACWY)
Meningococcal Groups A, C, W and Y Conjugate Vaccine (MenACWY)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03493919 | Mar 2018 → May 2022 | meningococcal meningitis | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Meningococcal Groups A, C, W and Y Conjugate Vaccine (MenACWY) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03493919 ↗ |
| Modality | Vaccine | “One dose of MenACWY vaccine were administered intramuscularly at Day 1.” NCT03493919 ↗ |
| Route | Intramuscular | “One dose of MenACWY vaccine were administered intramuscularly at Day 1.” NCT03493919 ↗ |